China Isotope & Radiation Stock

China Isotope & Radiation Liabilities 2024

China Isotope & Radiation Liabilities

8.5 B CNY

Ticker

1763.HK

ISIN

CNE1000031F4

In 2024, China Isotope & Radiation's total liabilities amounted to 8.5 B CNY, a 16.08% difference from the 7.32 B CNY total liabilities in the previous year.

China Isotope & Radiation Aktienanalyse

What does China Isotope & Radiation do?

China Isotope & Radiation Corp (CIRC) is a Chinese company specialized in the production and sale of nuclear products and services. It was founded in 1990 and is headquartered in Beijing. CIRC's history dates back to the 1950s when China conducted atomic experiments. In the 1960s, the country began producing radioisotopes for use in medicine, industry, and agriculture. CIRC was later established as a company to organize the production and sale of these products and services. CIRC's business model is based on the production and sale of radioisotopes and their applications in various fields such as medicine, industry, environmental monitoring, and research. The company aims to provide high-quality products and services to meet its customers' needs. CIRC has different divisions focusing on the various applications of radioisotopes. One important division is the medical application, which focuses on the production of radioisotopes for cancer diagnosis and therapy, cardiovascular diseases, and other illnesses. The company also produces radioactive drugs that can be used in the diagnosis and treatment of various diseases. Another important division of CIRC is the industrial application of radioisotopes, which focuses on the measurement of thickness, density, and radiation in various products and materials. The company also offers services in surface treatment and material testing. CIRC is also involved in environmental monitoring, offering products and services for the measurement and monitoring of air, water, and soil pollution. The company is also engaged in research and development, developing new products and applications of radioisotopes. CIRC offers a wide range of products, including various types of radioisotopes, radioactive drugs, radiation measurement devices and systems, as well as instruments and equipment for radioisotope production. CIRC is a leading provider of radioisotopes and related services in China and has a strong presence in other countries as well. The company has established itself as a reliable partner for customers in various industries and is committed to the highest quality and customer satisfaction. China Isotope & Radiation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing China Isotope & Radiation's Liabilities

China Isotope & Radiation's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating China Isotope & Radiation's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing China Isotope & Radiation's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

China Isotope & Radiation's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in China Isotope & Radiation’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about China Isotope & Radiation stock

What is the level of liabilities of China Isotope & Radiation this year?

China Isotope & Radiation has a debt balance of 8.5 B CNY this year.

What were the liabilities of China Isotope & Radiation compared to the previous year?

The liabilities of China Isotope & Radiation have increased by 16.08% increased compared to the previous year.

What are the consequences of high debt for investors of China Isotope & Radiation?

High liabilities can pose a risk for investors of China Isotope & Radiation, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in China Isotope & Radiation?

Low liabilities mean that China Isotope & Radiation has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of China Isotope & Radiation affect the company?

An increase in liabilities of China Isotope & Radiation can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of China Isotope & Radiation affect the company?

A decrease in the liabilities of China Isotope & Radiation can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of China Isotope & Radiation?

Some factors that can influence the liabilities of China Isotope & Radiation include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of China Isotope & Radiation so important for investors?

The liabilities of China Isotope & Radiation are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can China Isotope & Radiation take to modify the liabilities?

To change its liabilities, China Isotope & Radiation can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does China Isotope & Radiation pay?

Over the past 12 months, China Isotope & Radiation paid a dividend of 0.48 CNY . This corresponds to a dividend yield of about 5.55 %. For the coming 12 months, China Isotope & Radiation is expected to pay a dividend of 0.51 CNY.

What is the dividend yield of China Isotope & Radiation?

The current dividend yield of China Isotope & Radiation is 5.55 %.

When does China Isotope & Radiation pay dividends?

China Isotope & Radiation pays a quarterly dividend. This is distributed in the months of August, July, July, October.

How secure is the dividend of China Isotope & Radiation?

China Isotope & Radiation paid dividends every year for the past 8 years.

What is the dividend of China Isotope & Radiation?

For the upcoming 12 months, dividends amounting to 0.51 CNY are expected. This corresponds to a dividend yield of 5.89 %.

In which sector is China Isotope & Radiation located?

China Isotope & Radiation is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Isotope & Radiation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Isotope & Radiation from 11/22/2024 amounting to 0.072 CNY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did China Isotope & Radiation pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of China Isotope & Radiation in the year 2023?

In the year 2023, China Isotope & Radiation distributed 0.44 CNY as dividends.

In which currency does China Isotope & Radiation pay out the dividend?

The dividends of China Isotope & Radiation are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Isotope & Radiation

Our stock analysis for China Isotope & Radiation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Isotope & Radiation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.